K Number
K240108
Device Name
Wrap Accessory Electrodes (GMX-ABSBELT01; GMX-ABSBELT02; GMX-WRIST01; GMX-ELBOW01; GMX-LEG01, GMX-ANKLE01, GMX-KNEE01; GMX-FOOT PAD01; GMX-GLOVES01; SHOULDER01; GMX-NCK01)
Date Cleared
2024-06-10

(146 days)

Product Code
Regulation Number
882.1320
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Wrap Accessory Electrodes are intended to be used with legally marketed electrical stimulating devices such as transcutaneous electrical nerve stimulators or powered muscle stimulators. The wrap accessory electrodes will deliver the stimulation signals generated by the stimulator to the body surface with which they are in contact. The wrap accessory electrodes, made up of conductive silicone rubber, can be used for the stimulation on the body areas such as abdomen, neck, shoulder, elbow, leg, Hand, wrist, ankle, knee and foot.
Device Description
Wrap Accessory Electrodes with GMX-ABSBELT01、GMX-ABSBELT02、GMX-WRIST01、 GMX-ELBOW01、GMX-LEG 01、GMX-ANKLE01、GMX-KNEE01、GMX-FOOT PAD 01、 GMX-GLOVES 01、SHOULDER01、GMX-NCK01, are intended to be used with legally Marketed transcutaneous electrical nerve stimulators or powered muscle stimulators which could be used in place of traditional cutaneous electrode patches. The different series of model means different placement of the Wrap Accessory Electrodes. The wrap accessory electrodes will deliver the stimulation signals generated by the stimulator to the body surface with which they are in contact. The wrap accessory electrodes, made up of conductive silicone rubber, can be used for the stimulation on the body areas such as abdomen, neck, shoulder, elbow, leg, Hand, wrist, ankle, knee and foot.
More Information

Not Found

No
The device description and performance studies focus on the physical properties and electrical conductivity of the electrodes, with no mention of AI or ML for signal processing, analysis, or control.

No
The device described is an accessory electrode intended to deliver stimulation signals generated by a separate stimulator, such as a transcutaneous electrical nerve stimulator or powered muscle stimulator. It does not generate the therapeutic signals itself; rather, it functions as a conduit for a therapeutic device.

No

The device is described as electrodes that deliver stimulation signals, intended for use with electrical stimulating devices like TENS or powered muscle stimulators. Its purpose is to deliver stimulation, not to diagnose a condition.

No

The device is described as "Wrap Accessory Electrodes" made of "conductive silicone rubber" and is intended to deliver stimulation signals. This description clearly indicates a physical hardware component, not software.

Based on the provided text, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
  • Device Function: The description clearly states that the Wrap Accessory Electrodes are used with electrical stimulating devices (TENS or powered muscle stimulators) to deliver stimulation signals to the body surface. This is an external application, not an analysis of samples taken from the body.
  • Intended Use: The intended use is for delivering electrical stimulation for therapeutic purposes (implied by the use with TENS and muscle stimulators), not for diagnostic testing of biological samples.

The device is an accessory for electrical stimulation, which falls under a different regulatory category than IVDs.

N/A

Intended Use / Indications for Use

The Wrap Accessory Electrodes are intended to be used with legally marketed electrical stimulating devices such as transcutaneous electrical nerve stimulators or powered muscle stimulators. The wrap accessory electrodes will deliver the stimulation signals generated by the stimulator to the body surface with which they are in contact. The wrap accessory electrodes, made up of conductive silicone rubber, can be used for the stimulation on the body areas such as abdomen, neck, shoulder, elbow, leg, Hand, wrist, ankle, knee and foot.

Product codes (comma separated list FDA assigned to the subject device)

GXY

Device Description

Wrap Accessory Electrodes with GMX-ABSBELT01、GMX-ABSBELT02、GMX-WRIST01、 GMX-ELBOW01、GMX-LEG 01、GMX-ANKLE01、GMX-KNEE01、GMX-FOOT PAD 01、 GMX-GLOVES 01、SHOULDER01、GMX-NCK01, are intended to be used with legally Marketed transcutaneous electrical nerve stimulators or powered muscle stimulators which could be used in place of traditional cutaneous electrode patches. The different series of model means different placement of the Wrap Accessory Electrodes. The wrap accessory electrodes will deliver the stimulation signals generated by the stimulator to the body surface with which they are in contact. The wrap accessory electrodes, made up of conductive silicone rubber, can be used for the stimulation on the body areas such as abdomen, neck, shoulder, elbow, leg, Hand, wrist, ankle, knee and foot.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

abdomen, neck, shoulder, elbow, leg, Han, wrist, ankle, knee and foot.

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The proposed device is the same as the predicate device but the two devices are different. A series of safety and performance tests were conducted on the subject device: Biocompatibility, Electromagnetic compatibility and electrical safety, Function test with Maximum resistance value、Minimum resistance value、Maximum output voltage、Maximum output current、Maximum Phase charge、Maximum charge density、 Maximum average power density、hot spot test and impedance per area. All the test results demonstrate Wrap Accessory Electrodes meets the requirements of its pre-defined acceptance criteria and intended uses and is substantially equivalent to the predicate devices.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K210383, K190617

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 882.1320 Cutaneous electrode.

(a)
Identification. A cutaneous electrode is an electrode that is applied directly to a patient's skin either to record physiological signals (e.g., the electroencephalogram) or to apply electrical stimulation.(b)
Classification. Class II (performance standards).

0

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: a symbol on the left and the FDA name and title on the right. The symbol on the left is a stylized representation of a human figure, while the text on the right reads "FDA U.S. FOOD & DRUG ADMINISTRATION" in blue letters.

June 10, 2024

Gymmax Technology Shenzhen Co., Ltd. % Salon Chen System engineer IMD Medical & Drug technology service institutions Room 308, Building 11, No. 23 Jinqu Road, Wanjiang District Dongguan, Guangdong 523039 China

Re: K240108

Trade/Device Name: Wrap Accessory Electrodes (GMX-ABSBELT01, GMX-ABSBELT02, GMX-WRIST01, GMX-ELBOW01, GMX-LEG 01, GMX-ANKLE01, GMX-KNEE01, GMX-FOOT PAD 01, GMX-GLOVES 01, SHOULDER01, GMX-NCK01) Regulation Number: 21 CFR 882.1320 Regulation Name: Cutaneous Electrode Regulatory Class: Class II Product Code: GXY Dated: May 13, 2024 Received: May 14, 2024

Dear Salon Chen:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrb/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

1

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).

Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely.

Heather L. Dean -S

Heather Dean, PhD Assistant Director DHT5B: Division of Neuromodulation and Rehabilitation Devices

2

OHT5: Office of Neurological and Physical Medicine Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

3

Indications for Use

Submission Number (if known)

K240108

Device Name

Wrap Accessory Electrodes (GMX-ABSBELT01、GMX-ABSBELT02、GMX-WRIST01、GMX-ELBOW01、GMX-LEG 01、GMX-ANKLE01、GMX-KNEE01、GMX-FOOT PAD 01、GMX-GLOVES 01、SHOULDER01、GMX-NCK01)

Indications for Use (Describe)

The Wrap Accessory Electrodes are intended to be used with legally marketed electrical stimulating devices such as transcutaneous electrical nerve stimulators or powered muscle stimulators. The wrap accessory electrodes will deliver the stimulation signals generated by the stimulator to the body surface with which they are in contact. The wrap accessory electrodes, made up of conductive silicone rubber, can be used for the stimulation on the body areas such as abdomen, neck, shoulder, elbow, leg, hand, wrist, ankle, knee and foot .

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

X Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

4

510(k) Summary

1. Submitter's Identification:

  • Company Name: Gymmax Technology Shenzhen Co., Ltd.

  • Establishment Registration Number: 3007689716

  • Address:5F 4th Bldg., Heping Complex (4th Bldg. Huimingsheng Technology Park) Fuhai Subdistrict, Baoan District Shenzhen City, Guangdong Province 518103 P.R.C.

  • Phone: +86-755-2912-4050

  • A Fax: +86-755-2912-4050
  • Contact Person (Title): Benson Wang (General Manager)

  • E-mail: benson gmx@gq.com

  • Date of Preparation: May 04, 2024

    1. Common Name and Classification:
  • Regulation Name: Cutaneous Electrode

  • Classification Product Code: GXY

  • Regulation Number: 21 CFR 882.1320

  • Regulatory Class: Class II

  • Review Panel: Neurology

  • Trade Name: Wrap Accessory Electrodes

  • Predicate Device Information1: 3.
  • 510(k) Number: K210383

  • Predicate Device Name: Wrap Accessory Electrodes

  • Manufacturer: Hi-Dow International Inc.

  • A Intended Use:

The Wrap Accessory Electrodes are intended to be used with legally marketed electrical stimulating devices such as transcutaneous electrical nerve stimulators or powered muscle stimulators. The wrap accessory electrodes will deliver the stimulation signals generated by the stimulator to the body surface with which they are in contact. The wrap accessory electrodes,

5

made up of conductive silicone rubber, can be used for the stimulation on the body areas such as back, neck, shoulder, elbow, wrist, knee and foot.

    1. Predicate Device Information2:
  • 510(k) Number: K190617

  • Predicate Device Name: Wrap accessory electrodes

  • Manufacturer: Hi-Dow International Inc.

> Intended Use:

Wrap accessory electrodes, available in a glove style, are cutaneous electrodes intended to be used with legally marketed TENS or EMS stimulating devices. The Wrap accessory electrodes are non-sterile reusable OTC conductive garments that are intended to deliver the stimulation signals generated by the stimulator to the body surface with which they are in contact. These body parts can include the hands (gloves) and feet (socks). It is intended for adult patients.

5. Application Correspondent

  • Company Name: IMD Medical & Drug technology service institutions

  • Phone: +86-18613190779

  • Fax: +86-755-62809168

  • Contact Person (Title): Salon Chen (System engineer)

  • E-mail: 33999439@gq.com

  • Address: Room 308, Building 11, No. 23 Jinqu Road, Wanjiang District, Dongguan City, Guangdong Province, China

6. Device Description

Wrap Accessory Electrodes with GMX-ABSBELT01、GMX-ABSBELT02、GMX-WRIST01、 GMX-ELBOW01、GMX-LEG 01、GMX-ANKLE01、GMX-KNEE01、GMX-FOOT PAD 01、 GMX-GLOVES 01、SHOULDER01、GMX-NCK01, are intended to be used with legally Marketed transcutaneous electrical nerve stimulators or powered muscle stimulators which could be used in place of traditional cutaneous electrode patches. The different series of model means different placement of the Wrap Accessory Electrodes. The wrap accessory electrodes will deliver the stimulation signals generated by the stimulator to the body surface with which they are in contact.

6

The wrap accessory electrodes, made up of conductive silicone rubber, can be used for the stimulation on the body areas such as abdomen, neck, shoulder, elbow, leg, Hand, wrist, ankle, knee and foot.

7. Indications for Use

The Wrap Accessory Electrodes are intended to be used with legally marketed electrical stimulating devices such as transcutaneous electrical nerve stimulators or powered muscle stimulators. The wrap accessory electrodes will deliver the stimulation signals generated by the stimulator to the body surface with which they are in contact. The wrap accessory electrodes, made up of conductive silicone rubber, can be used for the stimulation on the body areas such as abdomen, neck, shoulder, elbow, leg, Hand, wrist, ankle, knee and foot.

8. Comparison to the predicate device

| Elements of
Comparison | Proposed Device
K240108 | Predicate Device 1
K210383 | Predicate Device 2
K190617 | Judgment |
|-----------------------------------|-----------------------------------------|-------------------------------|-------------------------------|----------|
| Company
Name | Gymmax Technology
Shenzhen Co., Ltd. | Hi-Dow International Inc. | Hi-Dow International Inc. | / |
| Device Name | Wrap Accessory
Electrodes | Wrap Accessory
Electrodes | Wrap Accessory
Electrodes | / |
| Classification
Product
Code | GXY | GXY | GXY | SE |
| Regulation | 21 CFR 882.1320 | 21 CFR 882.1320 | 21 CFR 882.1320 | SE |
| Classification
Name | Electrode, Cutaneous | Electrode, Cutaneous | Electrode, Cutaneous | SE |
| Class | 2 | 2 | 2 | SE |
| Prescription
or OTC | OTC | OTC | OTC | SE |

8.1 Table 1 General Comparison

7

Intended UseThe Wrap Accessory Electrodes are intended to be used with legally marketed electrical stimulating devices such as transcutaneous electrical nerve stimulators or powered muscle stimulators. The wrap accessory electrodes will deliver the stimulation signals generated by the stimulator to the body surface with which they are in contact. The wrap accessory electrodes, made up of conductive silicone rubber, can be used for the stimulation on the body areas such as abdomen, neck, shoulder, elbow, leg, Hand, wrist, ankle, knee and foot.The Wrap Accessory Electrodes are intended to be used with legally marketed electrical stimulating devices such as transcutaneous electrical nerve stimulators or powered muscle stimulators. The wrap accessory electrodes will deliver the stimulation signals generated by the stimulator to the body surface with which they are in contact. The wrap accessory electrodes, made up of conductive silicone rubber, can be used for the stimulation on the body areas such as back, neck, shoulder, elbow, wrist, knee and foot.Wrap accessory electrodes, available in a glove style or socks style, are cutaneous electrodes intended to be used with legally marketed TENS or EMS stimulating devices. The Wrap accessory electrodes are non-sterile reusable OTC conductive garments that are intended to deliver the stimulation signals generated by the stimulator to the body surface with which they are in contact. These body parts can include the hands (gloves) and feet (socks). It is intended for adult patients.Note1
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Table 1 General Comparison

Note 1: As shown in the above comparison Table,Proposed Device adds and can be used for the stimulation on the body areas such as abdomen, leg, ankle and foot. Electronic pulses are sent through electrode pads to passively exercise the affected muscle. EMS sends comfortable impulses through your skin that stimulates the nerves in the treatment area, in the same way, TENS or EMS is effect in other areas of the body areas, they are all used to deliver the stimulation signals generated by electrical stimulator to the body surface, the difference does not raise new questions of safety and effectiveness as compared to the predicate devices.

8

8.2Table 2 Safety factor & Performance Comparison

| Safety factor &

PerformanceProposed DevicePredicate Device1Predicate Device2Judgment
impedance per area
( $Ω/in.²$ ) as a
worst-case
condition12.5//Note 2
BiocompatiblityCompliance with ISO
10993-1Compliance with ISO
10993-1Compliance with ISO
10993-1SE

Table 2 Safety factor & Performance Comparison

Note 2: Electrode conductive area and Impedance Parameters Although the subject device has 12.5 Ω per inch, which is different from the predicate device, "Maximum Average Current Density" and "Maximum Peak Power Density" property are similar and do not raise new questions of safety or effectiveness. The standard of "Maximum Average Current Density" refers to "IEC60601-2-10 Clause 201.4.2" and the standard of "Maximum Peak Power Density" refer to "Guidance Document for Powered Muscle Stimulator 510K Section 3." Indicating similar performance and safety between subject device and predicate device. Otherwise, the subject devices are complying with ISO 10993 requirements. So, the differences of the function specifications will not raise any safety or effectiveness issue. For detailed measurement data, please refer to the above table. The subject device is Substantially Equivalent to the predicate device.

Electrical Stimulator System has applied for K232439 with Models: GMX-007 and GMX-006, Electrical Stimulator System with Wrap Accessory Electrodes have been tested with below:

1) Basic Safety and Essential Performance _

IEC 60601-1-11:2020: General Requirements For Basic Safety And Essential Performance -Collateral Standard: Requirements For Medical Electrical Equipment And Medical Electrical Systems Used In The Home Healthcare Environment.

IEC 60601-2-10:2012 +A1:2016+A2:2023medical electrical equipment - part 2-10: particular requirements for the basic safety and essential performance of nerve and muscle stimulators. IEC 60601-1-6 :2010+A1:2013+A2:2020 Medical Electrical Equipment - Part 1-6: General Requirements For Basic Safety And Essential Performance - Collateral Standard: Usability.

  1. Biocompatibility testing

9

ISO 10993-1:2009 Biological evaluation of medical devices-Parts 1: Evaluation and testing.

ISO 10993-10:2021 Biological evaluation of medical devices-Parts 10: Tests for skin sensitization

ISO 10993-23:2021 Biological evaluation of medical devices-Parts 10: Tests for irritation

    1. Maximum output voltage (volts+/-20%) at 500Ω、Maximum output voltage (volts+/-20%) at 2KΩ、 Maximum output voltage (volts+/-20%) at 10KΩ、Maximum output current (mA+/-20%) at 500Ω、 Maximum output current (mA+/-20%) at 2KΩ、Maximum output current (mA+/-20%) at 10KΩ

| Safety factor &

PerformanceProposed Device
Maximum
output voltage
(volts+/-20%) at
$500Ω$TENS 1:112
TENS 2: 114
STIM1:116
STIM2:116
STIM3:76
STIM4: 70
Maximum
output voltage
(volts+/-20%) at
$2kΩ$TENS 1: 250
TENS 2: 240
STIM1: 250
STIM2: 250
STIM3: 158
STIM4: 146
Maximum
output voltage
(volts+/-20%) at
$10kΩ$TENS 1: 300
TENS 2: 286
STIM1: 310
STIM2: 308
STIM3: 278
STIM4: 276
Maximum
output current
(mA+/-20%) at
$500Ω$TENS 1: 224
TENS 2: 228
STIM1: 232
STIM2: 232
STIM3: 152
STIM4: 140
Maximum
output current
(mA+/-20%) at
$2kΩ$TENS 1:125
TENS 2: 120
STIM1: 125
STIM2: 125
STIM3:79
STIM4: 73

10

| Maximum
output current
(mA+/-20%) at
10KΩ | TENS 1: 30
TENS 2: 28.6
STIM1: 31
STIM2:30.8
STIM3: 27.8
STIM4: 27.6 |
|------------------------------------------------------------|----------------------------------------------------------------------------------------------|
| Pulse period
(mSec) | 20~200 |
| Frequency (Hz) | TENS 1: 33
TENS 2: 5
STIM1:37
STIM2:25
STIM3: 5
STIM4: 50 |
| Maximum Phase
charge (µC) at
500Ω | TENS 1: 11
TENS 2: 11
STIM1: 11.4
STIM2: 10.6
STIM3: 22.8
STIM4: 20.4 |
| Maximum
charge density
(mA/cm²) at
500Ω | TENS 1: 0.024
TENS 2: 0.01
STIM1:0.027
STIM2: 0.021
STIM3: 0.021
STIM4: 0.059 |
| Maximum
average power
density
(mW/cm²) at
500Ω | TENS 1: 1.33
TENS 2: 0.554
STIM1: 1.54
STIM2: 1.13
STIM3: 0.793
STIM4: 2.01 |

9. Discussion of Non-clinical Tests Performed for Determination of Substantial Equivalence are as follows:

The proposed device is the same as the predicate device but the two devices are different. A

series of safety and performance tests were conducted on the subject device:

Biocompatibility

Electromagnetic compatibility and electrical safety

Function test with Maximum resistance value、Minimum resistance value、Maximum output

11

voltage、Maximum output current、Maximum Phase charge、Maximum charge density、 Maximum average power density、hot spot test and impedance per area. All the test results demonstrate Wrap Accessory Electrodes meets the requirements of its pre-defined acceptance criteria and intended uses and is substantially equivalent to the predicate devices.

10. Clinical Tests Performed

No clinical test data was used to support the decision of substantial equivalence.

11. Conclusion

The subject devices have all features of the predicate devices. The few differences do not affect the safety and effectiveness of the subject devices.

Thus, the subject devices are substantially equivalent to the predicate devices.